Elke Niebergall‐Roth

NeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers”.

Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers

Stem Cell Research & Therapy(2022)10.1186/s13287-022-03156-9

N/A

1.6DataRank · unranked

73 citations

Kathrin Dieter, Elke Niebergall‐Roth, Sabrina Klingele, Michael Jünger, Christoph Hasslacher +22 more

Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

JCI Insight(2021)10.1172/jci.insight.151922

N/A

1.1DataRank · unranked

81 citations

Kathrin Dieter, Elke Niebergall‐Roth, Silvia Fluhr, Cristina Daniele, Jasmina Esterlechner +23 more

ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa

Cytotherapy(2023)10.1016/j.jcyt.2023.01.015

N/A

0.535DataRank · unranked

19 citations

Elke Niebergall‐Roth, Cristina Daniele, Silvia Fluhr, Natasha Y. Frank, Christoph Ganss +6 more

Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers

Research Square(2022)10.21203/rs.3.rs-1508134/v1

N/A

0.208DataRank · unranked

3 citations

Andreas Kerstan, Kathrin Dieter, Elke Niebergall‐Roth, Sabrina Klingele, Michael Jünger +22 more

Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

Stem Cell Research & Therapy(2021)10.1186/s13287-021-02272-2

N/A

0DataRank · unranked

37 citations

Jasmina Esterlechner, Elke Niebergall‐Roth, Ulf Dehio, Samar Sadeghi, Hannes M. Schröder +15 more

Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5+ Mesenchymal Stromal Cell Treatment in Recessive Dystrophic Epidermolysis Bullosa

Preprints.org(2023)10.20944/preprints202305.0357.v1

N/A

0DataRank · unranked

2 citations

Kathrin Dieter, Cristina Daniele, Silvia Fluhr, Maria Khokhrina, Inês Silva +4 more

Corrigendum to ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa [Cytotherapy 25 (2023) 782–788/1562]

Cytotherapy(2023)10.1016/j.jcyt.2023.06.001

N/A

0DataRank · unranked

0 citations

Elke Niebergall‐Roth, Cristina Daniele, Silvia Fluhr, Natasha Y. Frank, Christoph Ganss +6 more

Potency assay to predict the anti-inflammatory capacity of a cell therapy product for macrophage-driven diseases: overcoming the challenges of assay development and validation

Cytotherapy(2024)10.1016/j.jcyt.2024.02.004

N/A

0DataRank · unranked

7 citations

Laura Nimtz, Elke Niebergall‐Roth, Alexandra Norrick, Stefan Hägele, Lena Vollmer +6 more